Total adverse events · glabellar lines
Summary of Findings Table ‐ OnabotulinumtoxinA 20U showed no clear difference in total adverse events compared with placebo (low certainty).
1 finding from 1 review
Total adverse events · glabellar lines
Summary of Findings Table ‐ AbobotulinumtoxinA 50U may leads to higher total adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events (any) · people with asthma
Anti‐IL13 or anti‐IL4 agents leads to higher adverse events (any) compared with placebo (high certainty).
1 finding from 1 review
Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea
It is very uncertain whether continuous positive airway pressure (CPAP) changes minor adverse events compared with phosphodiesterase type 5 inhibitors (very low certainty).
1 finding from 1 review
Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Any adverse events ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Total adverse events · children aged 5 to 11 years with ASD
D‐cycloserine showed no clear difference in total adverse events compared with placebo (low certainty).
1 finding from 1 review
Minor adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse events · people with active UC
It is very uncertain whether probiotics changes minor adverse events compared with placebo (very low certainty).
1 finding from 1 review
Minor adverse events · people with active UC
It is very uncertain whether probiotics changes minor adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review
Intervention not reported
Major adverse events · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
It is very uncertain whether the intervention changes major adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Minor adverse events · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in minor adverse events (low certainty).
1 finding from 1 review
Major adverse events · people with acute cardiogenic shock
1 finding from 1 review
Major adverse events · men with lower urinary tract symptoms suggesting benign prostatic hyperplasia
It is very uncertain whether convective radiofrequency water vapour thermal therapy changes major adverse events compared with sham procedure (very low certainty).
1 finding from 1 review
Adverse events: ESKD · idiopathic steroid‐resistant nephrotic syndrome in children
It is very uncertain whether cyclosporin changes adverse events: ESKD compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Other adverse events · adults and children > 12 with non‐allergic rhinitis
Intranasal corticosteroids showed no clear difference in other adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Minor adverse events · people undergoing cystoscopy
Antimicrobial showed no clear difference in minor adverse events compared with placebo or no antibiotics (low certainty).
1 finding from 1 review
Adverse events ‐ toxic reaction (short term) · patients with Helicobacter pylori infection
1 finding from 1 review
Major adverse events
It is very uncertain whether PUL changes major adverse events compared with sham (very low certainty).
1 finding from 1 review